NCT05369572

Brief Summary

By introducing artificial intelligence into Chinese medicine tongue diagnosis, we collated and collected tongue images, anxiety and depression scales and gastroscopy reports, mined and analysed the correlation between tongue images and bile reflux and anxiety and depression and constructed a prediction model to analyse the possibility of predicting bile reflux and anxiety and depression in patients based on tongue images.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 11, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

June 30, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

June 22, 2022

Status Verified

June 1, 2022

Enrollment Period

2 years

First QC Date

May 5, 2022

Last Update Submit

June 20, 2022

Conditions

Keywords

artificial intelligencetonguebile reflux

Outcome Measures

Primary Outcomes (6)

  • Sensitivity

    Sensitivity of artificial intelligence models Sensitivity = number of true positives / (number of true positives + number of false negatives) \* 100%.

    3 years

  • Specificity

    Specificity of Artificial Intelligence Models Specificity = number of true negatives / (number of true negatives + number of false positives)) \*100%

    3 years

  • Positive predictive values(PPV)

    Positive predictive values from artificial intelligence models Positive predictive value = true positive / (true positive + false positive) \*100%

    3 years

  • Negative predictive values (NPV)

    Negative predictive values for artificial intelligence models Negative Predictive Value = True Negative / (True Negative + False Negative) \*100%

    3 years

  • AUC (95% CI)

    area under the receiver operating characteristic curve (AUC),

    3 years

  • Accuracy

    Accuracy for artificial intelligence models Accuracy = (true positives + true negatives) / total number of subjects \* 100%

    3 years

Study Arms (2)

Bile Reflux Group

Gastroscopic reports of enrolled patients will be extracted and patients will be identified as having bile reflux according to Kellosalo J classification. Grade I: small amount of yellowish reflux emerging from the pyloric orifice and/or yellowish staining of the mucus lake, which is pale yellow in colour. Grade II: intermittent gush of reflux from the pyloric opening and/or yellowish staining of the mucus lake, which is dark yellow. Grade III: frequent gush of yellow-green reflux from the pyloric orifice and/or yellow-green mucus covering the stomach.

Non-biliary reflux group

Gastroscopic reports will be extracted from patients enrolled in the group that do not meet the Kellosalo J classification as the non-biliary reflux group.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients aged 18-80 years who will undergo gastroscopy and who fulfil the inclusion criteria and do not fulfil the exclusion criteria.

You may qualify if:

  • Patients aged 18 to 80 years who wish to undergo gastroscopy.
  • Patients have given their informed consent and signed the informed consent form.

You may not qualify if:

  • Serious heart, liver, kidney or other underlying illness, or mental illness.
  • Patients taking anti-anxiety or depression medication within 3 months.
  • Current H. pylori infection.
  • History of surgery on the digestive or biliary tract.
  • Peptic ulcer, malignant tumour of the digestive tract, etc.
  • Patients taking bismuth or other staining medications.
  • Pregnant or lactating women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Qilu hosipital

Jinan, Shandong, 250012, China

Location

MeSH Terms

Conditions

Bile Reflux

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System DiseasesDuodenogastric RefluxStomach DiseasesGastrointestinal Diseases

Study Officials

  • Xiuli Zuo, MD,PhD

    Qilu Hospital of Shandong University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Xiuli Zuo, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctoral supervisor of Qilu Hospital gastroenterology department

Study Record Dates

First Submitted

May 5, 2022

First Posted

May 11, 2022

Study Start

June 30, 2022

Primary Completion

June 30, 2024

Study Completion

June 30, 2025

Last Updated

June 22, 2022

Record last verified: 2022-06

Locations